KANSER METASTAZINDA WAVE DÜZENLEYİCİ KOMPLEKSİNİN MOLEKÜLER ROLÜ: KAPSAMLI BİR GENEL BAKIŞ

Abstract

Kanser metastazı, onkolojideki en büyük zorluklardan biridir ve kanser kaynaklı ölümlerin ana nedenidir. Metastatik süreç, kanser hücrelerinin aktif göçünü gerektirir ki bu da büyük ölçüde aktin sitoskeletonunun dinamik olarak yeniden düzenlenmesine bağlıdır. Bu derlemenin amacı, hücre göçünün kritik bir düzenleyicisi olan WAVE Düzenleyici Kompleksi'nin (WRC) moleküler yapısını, regülasyonunu ve kanser metastazındaki çok yönlü rolünü güncel literatür ışığında özetlemektir. WRC, Rac1 gibi sinyal moleküllerini Arp2/3 kompleksi aracılı aktin polimerizasyonuna bağlayan beş alt birimden oluşan bir komplekstir ve lamelipodyum gibi invaziv yapıların oluşumunda merkezi bir rol oynar. Literatür, WRC bileşenlerinin birçok agresif kanser türünde aşırı eksprese edildiğini ve bu durumun artan hücre invazyonu, metastaz potansiyeli ve kötü prognoz ile güçlü bir şekilde ilişkili olduğunu göstermektedir. Sonuç olarak, WRC, kanser hücrelerinin metastatik yetenek kazanmasında temel bir moleküler mekanizma olarak öne çıkmaktadır. Bu nedenle, WRC sinyal yolağının hedeflenmesi, kanserin yayılmasını önlemeye yönelik yeni anti-metastatik tedavi stratejilerinin geliştirilmesi için umut verici bir alan oluşturmaktadır.

Keywords

• Aktin Hücre İskeleti
• Arp 2/3 Kompleks
• Hücre Göçü
• Kanser Metastazı
• Wave Düzenleyici Kompleks (WRC)

THE MOLECULAR ROLE OF THE WAVE REGULATORY COMPLEX IN CANCER METASTASIS: A COMPREHENSIVE OVERVIEW

Abstract

Cancer metastasis is among the most critical challenges in oncology and accounts for a major share of cancer-related deaths. This progression necessitates the active motility of cancer cells, a phenomenon closely tied to the dynamic remodeling of the actin cytoskeleton. This review focuses on the molecular composition, regulatory dynamics, and diverse roles of the WAVE Regulatory Complex (WRC)—a pivotal player in cell migration—within the context of cancer dissemination, drawing upon the latest literature. Structurally, the WRC comprises five subunits that transmit signals from small GTPases such as Rac1 to the Arp2/3 complex, initiating actin polymerization. This process facilitates the formation of invasive cellular extensions like lamellipodia, which are instrumental in migratory behavior. Accumulating evidence reveals that WRC components are highly expressed in various aggressive malignancies, correlating strongly with enhanced invasion potential, increased metastatic capacity, and poor clinical outcomes. Thus, WRC-mediated signaling pathways emerge as promising therapeutic targets, potentially contributing to the design of novel anti-metastatic strategies aimed at halting cancer spread.

Keywords

• Actin cytoskeleton
• Arp 2/3 Complex
• Cancer Metastasis
• Cell Migration
• Wave Regulatory Complex

References

1. Algayadh, I. G., Dronamraju, V., & Sylvester, P. W. (2016). Role of Rac1/WAVE2 signaling in mediating the inhibitory effects of γ-tocotrienol on mammary cancer cell migration and invasion. Biological and Pharmaceutical Bulletin, 39(12), 1974–1982. https://doi.org/10.1248/bpb.b16-00461
2. Bompard, G., & Caron, E. (2004). Integrin signalling: a complex in the making. Trends in Cell Biology, 14(7), 350–353.
3. Cardama, G. A., et al. (2014). Rac inhibition as a novel therapeutic strategy in cancer. Oncotarget, 5(18), 8265–8277.
4. Chowdhury, N., & Drake, C. G. (2020). Kidney Cancer: An Overview of Current Therapeutic Approaches. Urologic Clinics of North America, 47(4), 419–431.
5. Chen, Z., et al. (2010). Structure and control of the actin regulatory WAVE complex. Nature, 468(7323), 533–538.
6. Collins, F. S., & Varmus, H. (2015). A new initiative on precision medicine. New England Journal of Medicine, 372(9), 793–795.
7. Cooper, G. M. (2016). The cell: A molecular approach (6th ed.). Sinauer Associates.
8. DeVita, V. T. Jr., Hellman, S., & Rosenberg, S. A. (2001). Cancer: Principles & practice of oncology (6th ed.). Lippincott Williams & Wilkins.

9. Ding, Z., Roos, A., Kloss, J., Dhruv, H., Peng, S., Pirrotte, P., … Loftus, J. C. (2018).A novel signaling comple between TROY and EGFR mediates glioblastoma cell invasion. Molecular Cancer Research, 16(2), 322–332.https://doi.org/10.1158/1541-7786.MCR-17-0454
10. Druker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J. M., Lydon, N. B., Baccarani, H., Deininger, J., Goldman, A., & Clark, J. M. (2001). Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. New England Journal of Medicine, 344(14), 1031–1037.
11. Ebi, H., Costa, C., Faber, A. C., Nishtala, M., Kotani, H., Juric, D., … Engelman, J. A. (2013). PI3K regulates MEK/ERK signaling in breast cancer via the Rac–PAK pathway. Cancer Research, 73(17), 5139–5149. https://doi.org/10.1158/0008-5472.CAN-13-1235
12. Eden, S., Rohatgi, R., Podtelejnikov, A. V., Mann, M., & Kirschner, M. W. (2002). Mechanism of regulation of WAVE1-induced actin nucleation by Rac1 and Nck. Nature, 418(6899), 790–793.
13. Escobar, B., de Cárcer, G., Fernández-Miranda, G., Cascón, A., Bravo-Cordero, J. J., Montoya, M. C., & Fernández-Capetillo, O. (2010). Brick1 is an essential regulator of actin cytoskeleton required for embryonic development and cell transformation. Cancer Research, 70(22), 9187–9197.
14. Esteva, A., Robicquet, A., Ramsundar, B., Kuleshov, V., DePristo, M., Chou, K., & Dean, S. (2019). A guide to deep learning in healthcare. Nature Medicine, 25(1), 24–29. https://doi.org/10.1038/s41591-018-0316-z
15. Frugtniet, B., Jiang, W. G., & Martin, T. A. (2015). Role of the WASP and WAVE family proteins in breast cancer invasion and metastasis. Breast Cancer (Dove Medical Press), 7, 141–150.
16. Gao, Y., Dickerson, J. B., Guo, F., Zheng, J., & Zheng, Y. (2004). Rational design and characterization of a Rac GTPase–specific small molecule inhibitor. Proceedings of the National Academy of Sciences, 101(20), 7618–7623.
17. Graham, J., Dudani, S., & Heng, D. Y. C. (2018). Prognostication in Kidney Cancer: Recent Advances and Future Directions. Journal of Clinical Oncology, 36(34), 3364–3372.
18. Hanahan, D., & Weinberg, R. A. (2011a). Hallmarks of cancer: the next generation. Cell, 144(5), 646–674.
19. Henriksen, K. J., & Chang, A. (2020). The Importance of Nephropathology in Kidney Cancer. Seminars in Nephrology, 40(1), 69–75.
20. Innocenti, M., Zucconi, A., Disanza, A., Frittoli, E., Areces, L. B., Steffen, A., & Machesky, L. M. (2004). Abi1 is essential for the formation and activation of a WAVE2 signalling complex. Nature Cell Biology, 6(4), 319–327.
21. Iwaya, K., Norio, K., & Mukai, K. (2007). Coexpression of Arp2 and WAVE1 predicts poor outcome in non–small cell lung carcinoma. Modern Pathology, 20(3), 339–343. https://doi.org/10.1038/modpathol.3800744
22. Krugmann, S., Jordens, I., Gevaert, K., Driessens, M., Vandekerckhove, J., & Hall, A. (2001). Cdc42 induces filopodia by promoting the formation of an IRSp53: Mena complex. Current Biology, 11(21), 1645–1655.
23. Kunda, P., Craig, G., Dominguez, V., & Baum, B. (2003). Abi, Sra1, and Kette control the stability and localization of SCAR/WAVE to regulate the formation of actin-based protrusions. Current Biology, 13(21), 1867–1875.
24. Kurisu, S., & Takenawa, T. (2010). WASP and WAVE family proteins: friends or foes in cancer invasion? Cancer Science, 101(10), 2110–2114.
25. Lane, J., Martin, T., Weeks, H. P., & Jiang, W. G. (2014). The WASP and WAVE family of proteins in cancer. Cancer Genomics & Proteomics, 11(3), 155–165.
26. Linehan, W. M., Zbar, B., & Marston, L. (2004). Focus on kidney cancer. Cancer Cell, 6(3), 221–224.
27. Lodish, H., Berk, A., Kaiser, C. A., Krieger, M., Bretscher, A., Ploegh, H., & Scott, M. P. (2008). Molecular Cell Biology (6th ed.). W. H. Freeman and Company.
28. Machesky, L. M., & Insall, R. H. (1998). Scar1 and the related Wiskott-Aldrich syndrome protein, WASP, regulate the actin cytoskeleton through the Arp2/3 complex. Current Biology, 8(25), 1347–1356.
29. Marchesin, V., Montagnac, G., & Chavrier, P. (2015). ARF6 promotes the formation of Rac1- and WAVE-dependent ventral F-actin rosettes in breast cancer cells in response to epidermal growth factor. PLoS ONE, 10(3), e0121747. https://doi.org/10.1371/journal.pone.0121747
30. Maude, S. L., Frey, K., Shaw, P. A., Aplenc, R., Barrett, D. M., Bunin, N., & Grupp, S. A. (2014). Chimeric antigen receptor T cells for sustained remissions in leukemia. New England Journal of Medicine, 371(16), 1507–1517.
31. Miki, H., & Takenawa, T. (2020). Cell motility mechanisms: Roles of Rac and WAVE2. FEBS Letters, 594(14), 2197–2207.
32. Nolen, B. J., et al. (2009). Characterization of two classes of small molecule inhibitors of Arp2/3 complex. Nature, 460(7258), 1031–1034.
33. Oikawa, K., Ohbayashi, T., Kiyono, T., Nishi, H., Isaka, K., Umezawa, A., & Ito, Y. (2004). Expression of a novel human gene, human wings apart-like (hWAPL), is associated with cervical carcinogenesis and tumor progression. Cancer Research, 64(10), 3545–3549.
34. Oikawa, T. (2004). ETS transcription factors: possible targets for cancer therapy. Cancer Science, 95(8), 626–633.
35. Pollard, T. D., & Borisy, G. G. (2003). Cellular motility driven by assembly and disassembly of actin filaments. Cell, 112(4), 453–465.
36. Rana, A., Verma, P., Rana, V., & Rana, D. S. (2021). WAVE2: A crucial regulator in cancer metastasis. Life Sciences, 281, 119726.
37. Rana, A., Verma, P., Rana, V., & Rana, D. S. (2022). WAVE2 as a promising therapeutic target for cancer: A review. Journal of Cancer Research and Therapeutics, 18(4), 841–849.
38. Rana, A., Verma, P., Rana, V., & Rana, D. S. (2023). Targeting WAVE2 in cancer therapy. Seminars in Cancer Biology, 96, 159–169.
39. Rana, P. S., Alkrekshi, A., Wang, W., Markovic, V., & Sossey-Alaoui, K. (2021). The role of WAVE2 signaling in cancer. Biomedicines, 9(9), 1217. https://doi.org/10.3390/biomedicines909121
40. Richard, S., Gardie, B., Couvé, C., & Giraud, S. (2010). VHL syndrome: from genetics to clinical practice. Medical Genetics Practice, 1(3), 193–206.
41. Rottner, K., & Stradal, T. E. (2016). Regulation of the Arp2/3 complex: new insights. Current Opinion in Cell Biology, 43, 9–16.
42. Rottner, K., & Stricker, P. (2021). The Arp2/3 complex in cell migration. Current Biology, 31(12), R761–R764.
43. Roy, S. P. S., & Saikia, S. (2016). Recent advances in cancer treatment. International Journal of Pharmaceutical Sciences Review and Research, 41(1), 1–8.
44. Shen, C., & Kaelin, W. G. (2010). The VHL/HIF axis in renal cell carcinoma. Cancer Cell, 18(4), 317–320.
45. Soderling, S. H., Binns, K. L., Wayman, G. A., Davee, S. M., Ong, S. H., Pawson, T., & Hampson, D. R. (2002). The WRP component of the WAVE-1 complex attenuates Rac-mediated signalling. Nature Cell Biology, 4(12), 970–975.
46. Sossey-Alaoui, K., Mroue, R., & Li, M. (2014). WAVE2 plays a critical role in melanoma cell invasion and metastasis. Cancer Cell International, 14(1), 1–13.
47. Steffen, A., Lappalainen, P., & Stradal, T. E. (2004). Regulation of the Arp2/3 complex by actin monomers. Journal of Cell Science, 117(23), 5679–5688.
48. Sossey-Alaoui, K., Li, X., & Cowell, J. K. (2007). c-Abl-mediated phosphorylation of WAVE3 is required for lamellipodia formation and cell migration. Journal of Biological Chemistry, 282(36), 26257–26265. https://doi.org/10.1074/jbc.M701996200
49. Suetsugu, S., Miki, H., & Takenawa, T. (2003). The WAVE2 complex is an essential mediator between Rac1 and Arp2/3 complex for the formation of lamellipodia. Biochemical and Biophysical Research Communications, 300(3), 629–637.
50. Taniuchi, K., Furihata, M., Naganuma, S., & Saibara, T. (2018). WAVE2 is associated with poor prognosis in pancreatic cancers and promotes cell motility and invasiveness by binding to ACTN4. Cancer Medicine, 7(11), 5733–5751.
51. Tan, Y., Tian, X., Luo, J., Zhu, H., Chu, Y., & Pei, L. (2020). WAVE2 is associated with colorectal cancer liver metastasis through activation of TGF-β1/YAP1 signaling. Frontiers in Oncology, 10, 585. https://doi.org/10.3389/fonc.2020.00585
52. Tang, Y., & Sun, X. (2024). Rac1: A regulator of cell migration and a potential target for cancer therapy. Cellular Signaling, 76, Article 110323. https://pubmed.ncbi.nlm.nih.gov/37049739/
53. Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, C. F., Smith, D. C., McDermott, D. F., & Pardoll, D. M. (2012). Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. New England Journal of Medicine, 366(26), 2443–2454.
54. Tyler, K. M., & Rosenberger, J. (2016). WASP-family verprolin-homologous protein (WAVE). In M. Schwab (Ed.), Encyclopedia of Cancer (pp. 4192–4193). Springer.
55. Wan, J. C. M., Massie, C., Garcia-Corbacho, J., Mouliere, F., Brenton, J. D., Turnbull, C., & Rosenfeld, N. (2017). Liquid biopsies come of age: towards implementation of circulating tumour DNA. Nature Reviews Cancer, 17(4), 223–238.
56. Weeks, H. P., Sanders, A. J., Kynaston, H. G., & Jiang, W. G. (2016). The Association Between WAVE1 and -3 and the ARP2/3 Complex in PC 3 Cells. Anticancer Research, 36(3), 1135–1142.
57. Zaimy, M., Ghasemian, A., Ghasemian, M., & Moghoofei, R. (2017). Cancer statistics in the 21st century. International Journal of Cancer Management, 10(11), e11674.
58. Zhang, X., & Wang, H. (2023). Role and mechanism of Arp2/3 complex signaling in cancer invasion and metastasis: A review. Molecular Cancer, 22, Article 87. https://pubmed.ncbi.nlm.nih.gov/37026902/